In contrast, T cells were reactive to the TP53 mutation‐derived peptides in HCC 25 (TP53 R90S) and HCC 448 (TP53 R90S) with HLA‐C binding (Figure 4F). This evidence concerns the gene TP53 and hepatocellular carcinoma.